Safe-Cross vessel wall detection technology approved in the US:
This article was originally published in Clinica
Executive Summary
Kensey Nash has received US FDA 510(k) clearance for its vessel wall detection technology. The Safe-Cross RF CTO system combines a guidance system and radiofrequency energy to safely cross and recanalise chronic total occlusions in the coronary and peripheral arteries. The clearance allows Kensey Nash, of Exton, Pennsylvania, to incorporate a new interferometer with greater dynamic range into the Safe-Cross console. This technology will allow the system to sense the vessel wall farther in advance, allowing the operator more time to adjust the direction of the wire. The updated console will undergo a period of user evaluations prior to broader market introduction. Kensey Nash expects to CE mark the new technology later this year.
You may also be interested in...
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.